Ahad Khalilnezhad
Overview
Explore the profile of Ahad Khalilnezhad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johansson A, Khalilnezhad A, Takizawa H, Mizuno H, Suda T, Umemoto T
Exp Hematol
. 2024 Jul;
138():104281.
PMID: 39009278
Under stress hematopoiesis, previous studies have suggested the migration of hematopoietic stem cells (HSCs) from bone marrow (BM) to extramedullary sites such as the spleen. However, there is little direct...
2.
Ma W, Ahmad S, Hashimoto M, Khalilnezhad A, Kataoka M, Arima Y, et al.
EMBO J
. 2024 Jan;
43(3):339-361.
PMID: 38238476
Hematopoietic stem cell (HSC) divisional fate and function are determined by cellular metabolism, yet the contribution of specific cellular organelles and metabolic pathways to blood maintenance and stress-induced responses in...
3.
Shin Park D, Kozaki T, Tiwari S, Moreira M, Khalilnezhad A, Torta F, et al.
Nature
. 2023 Nov;
623(7986):397-405.
PMID: 37914940
Microglia are specialized brain-resident macrophages that arise from primitive macrophages colonizing the embryonic brain. Microglia contribute to multiple aspects of brain development, but their precise roles in the early human...
4.
Ramirez-Valdez R, Baharom F, Khalilnezhad A, Fussell S, Hermans D, Schrager A, et al.
Cell Rep
. 2023 Jun;
42(6):112599.
PMID: 37279110
Therapeutic neoantigen cancer vaccines have limited clinical efficacy to date. Here, we identify a heterologous prime-boost vaccination strategy using a self-assembling peptide nanoparticle TLR-7/8 agonist (SNP) vaccine prime and a...
5.
Kvedaraite E, Milne P, Khalilnezhad A, Chevrier M, Sethi R, Lee H, et al.
Sci Immunol
. 2022 Dec;
7(78):eadd3330.
PMID: 36525505
Langerhans cell histiocytosis (LCH) is a potentially fatal neoplasm characterized by the aberrant differentiation of mononuclear phagocytes, driven by mitogen-activated protein kinase (MAPK) pathway activation. LCH cells may trigger destructive...
6.
Baharom F, Ramirez-Valdez R, Khalilnezhad A, Khalilnezhad S, Dillon M, Hermans D, et al.
Cell
. 2022 Oct;
185(23):4317-4332.e15.
PMID: 36302380
Therapeutic cancer vaccines are designed to increase tumor-specific T cell immunity. However, suppressive mechanisms within the tumor microenvironment (TME) may limit T cell function. Here, we assessed how the route...
7.
Bleriot C, Barreby E, Dunsmore G, Ballaire R, Chakarov S, Ficht X, et al.
Immunity
. 2021 Sep;
54(9):2101-2116.e6.
PMID: 34469775
Tissue macrophages are immune cells whose phenotypes and functions are dictated by origin and niches. However, tissues are complex environments, and macrophage heterogeneity within the same organ has been overlooked...
8.
Nakamizo S, Dutertre C, Khalilnezhad A, Zhang X, Lim S, Lum J, et al.
J Exp Med
. 2021 Jul;
218(9).
PMID: 34279540
Inflammatory skin diseases including atopic dermatitis (AD) and psoriasis (PSO) are underpinned by dendritic cell (DC)-mediated T cell responses. Currently, the heterogeneous human cutaneous DC population is incompletely characterized, and...
9.
Baharom F, Ramirez-Valdez R, Tobin K, Yamane H, Dutertre C, Khalilnezhad A, et al.
Nat Immunol
. 2020 Nov;
22(1):41-52.
PMID: 33139915
Personalized cancer vaccines are a promising approach for inducing T cell immunity to tumor neoantigens. Using a self-assembling nanoparticle vaccine that links neoantigen peptides to a Toll-like receptor 7/8 agonist...
10.
Sharma A, Seow J, Dutertre C, Pai R, Bleriot C, Mishra A, et al.
Cell
. 2020 Sep;
183(2):377-394.e21.
PMID: 32976798
We employed scRNA sequencing to extensively characterize the cellular landscape of human liver from development to disease. Analysis of ∼212,000 cells representing human fetal, hepatocellular carcinoma (HCC), and mouse liver...